Feb 19, 2026 07:00AM
Jan 7, 2026 07:00AM
Jan 6, 2026 07:00AM
Jan 6, 2026 07:00AM
Dec 18, 2025 04:05PM
Dec 18, 2025 07:00AM
Dec 18, 2025 07:00AM Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
Nov 20, 2025 07:00AM
Nov 12, 2025 07:00AM
Oct 30, 2025 07:00AM
Oct 16, 2025 07:00AM
Oct 9, 2025 07:00AM
Oct 6, 2025 08:15AM
Oct 6, 2025 08:15AM Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders® 
Sep 23, 2025 07:40AM
Sep 18, 2025 07:42AM
Sep 18, 2025 07:41AM
Sep 4, 2025 08:00AM
Sep 4, 2025 08:00AM
Aug 12, 2025 07:00AM
Jun 30, 2025 04:05PM Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
Jun 10, 2025 08:00AM
May 29, 2025 08:45AM
May 14, 2025 07:30AM
May 12, 2025 07:30AM
May 1, 2025 07:30AM
Apr 30, 2025 07:45AM
Apr 10, 2025 07:01AM Gain Therapeutics (GANX) Presents Additional Preclinical Data and Design of Phase 1b Clinical Study of GT-02287
Apr 10, 2025 07:00AM
Mar 28, 2025 08:30AM
Mar 27, 2025 07:00AM
Feb 6, 2025 08:45AM
Feb 6, 2025 08:45AM
Jan 8, 2025 08:01AM
Jan 8, 2025 08:00AM Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
Nov 25, 2024 06:51AM
Nov 14, 2024 04:05PM
Feb 6, 2024 09:56AM
Feb 6, 2024 08:03AM
Feb 6, 2024 08:00AM
Jan 31, 2024 08:03AM
Jan 31, 2024 08:00AM Gain Therapeutics’ CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update
Aug 28, 2023 07:01AM
Aug 28, 2023 07:00AM
Jan 31, 2022 04:05PM
Jan 31, 2022 04:05PM
Oct 26, 2021 08:00AM
Sep 8, 2021 09:20AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All